PDGF synergistically enhances IFN-γ-induced expression of CXCL10 in blood-derived macrophages: Implications for HIV dementia

Journal of Immunology

Volumn 179, Issue 5, 2007, Pages 2722-2730

  Dhillon, Navneet Kaur ^a   Peng, Fuwang ^a   Ransohoff, Richard M ^b   Buch, Shilpa ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; STAT PROTEIN; CXCL10 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEMENTIA; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; RNA STABILITY; SIGNAL TRANSDUCTION; TARGET CELL; TRANSCRIPTION INITIATION; UPREGULATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; METABOLISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AIDS DEMENTIA COMPLEX; CELLS, CULTURED; CHEMOKINE CXCL10; DRUG SYNERGISM; HUMANS; INTERFERON TYPE II; JANUS KINASES; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; PLATELET-DERIVED GROWTH FACTOR; RNA STABILITY; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 38449088892     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.5.2722     Document Type: Article

References (72)

1. Kolb, S. A., B. Sporer, F. Lahrtz, U. Koedel, H. W. Pfister, and A. Fontana. 1999. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-γ inducible protein 10. J. Neuroimmunol. 93: 172-181.
2. Kolson, D. L., and R. J. Pomerantz. 1996. AIDS dementia and HIV-1-induced neurotoxicity: possible pathogenic associations and mechanisms. J. Biomed. Sci. 3: 389-414.
3. Sanders, V. J., C. A. Pittman, M. G. White, G. Wang, C. A. Wiley, and C. L. Achim. 1998. Chemokines and receptors in HIV encephalitis. AIDS 12: 1021-1026.
4. McArthur, J. C., D. R. Hoover, H. Bacellar, E. N. Miller, B. A. Cohen, J. T. Becker, N. M. Graham, J. H. McArthur, O. A. Selnes, L. P. Jacobson, et al. 1993. Dementia in AIDS patients: incidence and risk factors: multicenter AIDS cohort study. Neurology 43: 2245-2252.
5. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J. Exp. Med. 166: 1084-1097.
6. Luster, A. D., J. C. Unkeless, and J. V. Ravetch. 1985. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315: 672-676.
7. Lane, B. R., S. R. King, P. J. Bock, R. M. Strieter, M. J. Coffey, and D. M. Markovitz. 2003. The C-X-C chemokine IP-10 stimulates HIV-1 replication. Virology 307: 122-134.
8. Sasseville, V. G., M. M. Smith, C. R. Mackay, D. R. Pauley, K. G. Mansfield, D. J. Ringler, and A. A. Lackner. 1996. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am. J. Pathol. 149: 1459-1467.
9. Westmoreland, S. V., J. B. Rottman, K. C. Williams, A. A. Lackner, and V. G. Sasseville. 1998. Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. Am. J. Pathol. 152: 659-665.
10. Sui, Y., L. Stehno-Bittel, S. Li, R. Loganathan, N. K. Dhillon, D. Pinson, A. Nath, D. Kolson, O. Narayan, and S. Buch. 2006. CXCL10-induced cell death in neurons: role of calcium dysregulation. Eur. J. Neurosci. 23: 957-964.
11. Sui, Y., R. Potula, N. Dhillon, D. Pinson, S. Li, A. Nath, C. Anderson, J. Turchan, D. Kolson, O. Narayan, and S. Buch. 2004. Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am. J. Pathol. 164: 1557-1566.
12. Vergote, D., G. S. Butler, M. Ooms, J. H. Cox, C. Silva, M. D. Hollenberg, J. H. Jhamandas, C. M. Overall, and C. Power. 2006. Proteolytic processing of SDF-1α reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc. Natl. Acad. Sci. USA 103: 19182-19187.
13. Asensio, V. C., J. Maier, R. Milner, K. Boztug, C. Kincaid, M. Moulard, C. Phillipson, K. Lindsley, T. Krucker, H. S. Fox, and I. L. Campbell. 2001. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J. Virol. 75: 7067-7077.
14. van Marle, G., S. Henry, T. Todoruk, A. Sullivan, C. Silva, S. B. Rourke, J. Holden, J. C. McArthur, M. J. Gill, and C. Power. 2004. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329: 302-318.
15. Kutsch, O., J. Oh, A. Nath, and E. N. Benveniste. 2000. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74: 9214-9221.
16. Majumder, S., L. Z. Zhou, P. Chaturvedi, G. Babcock, S. Aras, and R. M. Ransohoff. 1998. p48/STAT-1α-containing complexes play a predominant role in induction of IFN-γ-inducible protein, 10 kDa (IP-10) by IFN-γ alone or in synergy with TNF-α. J. Immunol. 161: 4736-4744.
17. Majumder, S., L. Z. Zhou, P. Chaturvedi, G. Babcock, S. Aras, and R. M. Ransohoff. 1998. Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines. J. Neurosci. Res. 54: 169-180.
18. Ohmori, Y., and T. A. Hamilton. 1993. Cooperative interaction between interferon (IFN) stimulus response element and κB sequence motifs controls IFN γ-and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J. Biol. Chem. 268: 6677-6688.
19. Ohmori, Y., and T. A. Hamilton. 1995. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J. Immunol. 154: 5235-5244.
20. Sui, Y., R. Potula, D. Pinson, I. Adany, Z. Li, J. Day, E. Buch, J. Segebrecht, F. Villinger, Z. Liu, et al. 2003. Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis. J Med. Primatol. 32: 229-239.
21. Potula, R., N. Dhillion, Y. Sui, C. A. Zien, K. Funa, D. Pinson, M. S. Mayo, D. K. Singh, O. Narayan, and S. Buch. 2004. Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am. J. Pathol. 165: 815-824.
22. Goppelt-Struebe, M., and M. Stroebel. 1995. Synergistic induction of monocyte chemoattractant protein-1 (MCP-1) by platelet-derived growth factor and interleukin-1. FEBS Lett. 374: 375-378.
23. Sridhar, P., Y. Liu, L. D. Chin, C. E. Borja, M. Mann, H. A. Skopicki, and R. R. Freter. 1999. Platelet-derived growth factor-stimulated expression of the MCP-1 immediate-early gene involves an inhibitory multiprotein complex. Mol. Cell. Biol. 19: 4219-4230.
24. Freter, R. R., J. A. Alberta, G. Y. Hwang, A. L. Wrentmore, and C. D. Stiles. 1996. Platelet-derived growth factor induction of the immediate-early gene MCP-1 is mediated by NF-κB and a 90-kDa phosphoprotein coactivator. J. Biol. Chem. 271: 17417-17424.
25. Conant, K., A. Garzino-Demo, A. Nath, J. C. McArthur, W. Halliday, C. Power, R. C. Gallo, and E. O. Major. 1998. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95: 3117-3121.
26. Ross, R., E. W. Raines, and D. F. Bowen-Pope. 1986. The biology of platelet-derived growth factor. Cell 46: 155-169.
27. Ross, R., D. F. Bowen-Pope, and E. W. Raines. 1985. Platelet-derived growth factor: its potential roles in wound healing, atherosclerosis, neoplasia, and growth and development. Ciba Found. Symp. 116: 98-112.
28. Ross, R., A. Faggiotto, D. Bowen-Pope, and E. Raines. 1984. The role of endothelial injury and platelet and macrophage interactions in atherosclerosis. Circulation 70: III77-III82.
29. Ross, R., and E. W. Raines. 1988. Platelet-derived growth factor: its role in health and disease. Adv. Exp. Med. Biol. 234: 9-21.
30. Antoniades, H. N., M. A. Bravo, R. E. Avila, T. Galanopoulos, J. Neville-Golden, M. Maxwell, and M. Selman. 1990. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J. Clin. Invest. 86: 1055-1064.
31. Heldin, C. H. 1995. Dimerization of cell-surface receptors in signal-transduction. Cell 80: 213-223.
32. Lane, T. E., M. J. Buchmeier, D. D. Watry, and H. S. Fox. 1996. Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system disease. Mol. Med. 2: 27-37.
33. Orandle, M. S., A. G. MacLean, V. G. Sasseville, X. Alvarez, and A. A. Lackner. 2002. Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. J. Virol. 76: 5797-5802.
34. Shapshak, P., R. Duncan, A. Minagar, P. Rodriguez de la Veda, R. V. Stewart, and K. Goodkin. 2004. Elevated expression of IFN-γ in the HIV-1 infected brain. Front. Biosci. 9: 1073-1081.
35. Dhillon, N. K., D. Pinson, S. Dhillon, O. Tawfik, M. Danley, M. Davis, O. Nemon, M. Mayo, A. Kumar, Y. J. Tsai, et al. 2007. Bleomycin treatment causes enhancement of virus replication in the lungs of SHIV infected macaques. Am. J. Physiol. 292: L1233-L1240.
36. Hamilton, T. A., N. Bredon, Y. Ohmori, and C. S. Tannenbaum. 1989. IFN-γ and IFN-β independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages. J. Immunol. 142: 2325-2331.
37. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
38. Darnell, J. E., Jr. 1998. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interferon Cytokine Res. 18: 549-554.
39. Alberta, J. A., K. R. Auger, D. Batt, P. Iannarelli, G. Hwang, H. L. Elliott, R. Duke, T. M. Roberts, and C. D. Stiles. 1999. Platelet-derived growth factor stimulation of monocyte chemoattractant protein-1 gene expression is mediated by transient activation of the phosphoinositide 3-kinase signal transduction pathway. J. Biol. Chem. 274: 31062-31067.
40. Katsoulidis, E., Y. Li, H. Mears, and L. C. Platanias. 2005. The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J. Interferon Cytokine Res. 25: 749-756.
41. Vockerodt, M., D. Pinkert, S. Smola-Hess, A. Michels, R. M. Ransohoff, H. Tesch, and D. Kube. 2005. The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulation. Int. J. Cancer. 114: 598-605.
42. Sun, D., and A. Ding. 2006. MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA. Nat. Immunol. 7: 375-381.
43. Crowe, S. M. 1995. Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection. Aust. N. Z. J. Med. 25: 777-783.
44. Kaul, M., G. A. Garden, and S. A. Lipton. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994.
45. Nath, A. 1999. Pathobiology of human immunodeficiency virus dementia. Semin. Neurol. 19: 113-127.
46. McArthur, J. C., N. Sacktor, and O. Selnes. 1999. Human immunodeficiency virus-associated dementia. Semin. Neurol. 19: 129-150.
47. Orenstein, J. M. 2001. The macrophage in HIV infection. Immunobiology 204: 598-602.
48. Glass, J. D., H. Fedor, S. L. Wesselingh, and J. C. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38: 755-762.
49. Tyor, W. R., S. L. Wesselingh, J. W. Griffin, J. C. McArthur, and D. E. Griffin. 1995. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9: 379-388.
50. Gray, F., H. Adle-Biassette, F. Brion, T. Ereau, I. le Maner, V. Levy, and G. Corcket. 2000. Neuronal apoptosis in human immunodeficiency virus infection. J. Neurovirol. 6(Suppl. 1): S38-S43.
51. Tannenbaum, C. S., J. Major, E. Poptic, P. E. DiCorleto, and T. A. Hamilton. 1989. Lipopolysaccharide-inducible macrophage early genes are induced in BALB/c 3T3 cells by platelet-derived growth factor. J. Biol. Chem. 264: 4052-4057.
52. Li, X., A. Ponten, K. Aase, L. Karlsson, A. Abramsson, M. Uutela, G. Backstrom, M. Hellstrom, H. Bostrom, H. Li, et al. 2000. PDGF-C is a new protease-activated ligand for the PDGF α-receptor. Nat. Cell Biol. 2: 302-309.
53. Bergsten, E., M. Uutela, X. Li, K. Pietras, A. Ostman, C. H. Heldin, K. Alitalo, and U. Eriksson. 2001. PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor. Nat. Cell Biol. 3: 512-516.
54. Vignais, M. L., H. B. Sadowski, D. Watling, N. C. Rogers, and M. Gilman. 1996. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol. Cell. Biol. 16: 1759-1769.
55. Inui, H., Y. Kitami, M. Tani, T. Kondo, and T. Inagami. 1994. Differences in signal transduction between platelet-derived growth factor (PDGF) α and β receptors in vascular smooth muscle cells: PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis. J. Biol. Chem. 269: 30546-30552.
56. Romashkova, J. A., and S. S. Makarov. 1999. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90.
57. Auger, K. R., L. A. Serunian, S. P. Soltoff, P. Libby, and L. C. Cantley. 1989. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57: 167-175.
58. Kawano, H., S. Kim, K. Ohta, T. Nakao, H. Miyazaki, T. Nakatani, and H. Iwao. 2003. Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression. J. Am. Soc. Nephrol. 14: 584-592.
59. Lackmann, M., A. G. Harpur, A. C. Oates, R. J. Mann, A. Gabriel, W. Meutermans, P. F. Alewood, I. M. Kerr, G. R. Stark, and A. F. Wilks. 1998. Biomolecular interaction analysis of IFN γ-induced signaling events in whole-cell lysates: prevalence of latent STAT1 in high-molecular weight complexes. Growth Factors 16: 39-51.
60. Shuai, K., A. Ziemiecki, A. F. Wilks, A. G. Harpur, H. B. Sadowski, M. Z. Gilman, and J. E. Darnell. 1993. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366: 580-583.
61. Muller, M., J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. G. Harpur, G. Barbieri, B. A. Witthuhn, C. Schindler, et al. 1993. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 366: 129-135.
62. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.
63. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFN γ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15: 563-591.
64. Nguyen, H., C. V. Ramana, J. Bayes, and G. R. Stark. 2001. Roles of phosphatidylinositol 3-kinase in interferon-γ-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J. Biol. Chem. 276: 33361-33368.
65. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.
66. Stephens, J. M., S. J. Lumpkin, and J. B. Fishman. 1998. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-γ in adipocytes. J. Biol. Chem. 273: 31408-31416.
67. Caldenhoven, E., M. Buitenhuis, T. B. van Dijk, J. A. Raaijmakers, J. W. Lammers, L. Koenderman, and R. P. de Groot. 1999. Lineage-specific activation of STAT3 by interferon-γ in human neutrophils. J. Leukocyte Biol. 65: 391-396.
68. Orlovsky, K., L. Theodor, H. Malovani, Y. Chowers, and U. Nir. 2002. Gamma interferon down-regulates Fer and induces its association with inactive Stat3 in colon carcinoma cells. Oncogene 21: 4997-5001.
69. Horvath, C. M. 2000. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci. 25: 496-502.
70. Heldin, C. H., and B. Westermark. 1999. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79: 1283-1316.
71. Rani, M. R., and R. M. Ransohoff. 2005. Alternative and accessory pathways in the regulation of IFN-β-mediated gene expression. J. Interferon Cytokine Res. 25: 788-798.
72. Peruzzi, F., V. Bergonzini, S. Aprea, K. Reiss, B. E. Sawaya, J. Rappaport, S. Amini, and K. Khalili. 2005. Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: implication for HIV-associated dementia. Brain Res. Brain Res. Rev. 50: 114-125.